{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T19:53:24Z","timestamp":1772567604643,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,1,12]],"date-time":"2010-01-12T00:00:00Z","timestamp":1263254400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1007\/s00408-009-9217-8","type":"journal-article","created":{"date-parts":[[2010,1,11]],"date-time":"2010-01-11T12:23:58Z","timestamp":1263212638000},"page":"125-132","source":"Crossref","is-referenced-by-count":35,"title":["Thiopurine S-Methyltranferase Testing in Idiopathic Pulmonary Fibrosis: A Pharmacogenetic Cost-Effectiveness Analysis"],"prefix":"10.1007","volume":"188","author":[{"given":"Jared T.","family":"Hagaman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brent W.","family":"Kinder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark H.","family":"Eckman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,1,12]]},"reference":[{"key":"9217_CR1","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1164\/ajrccm.161.2.ats3-00","volume":"161","author":"American Thoracic Society","year":"2000","unstructured":"American Thoracic Society (2000) Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 161:646\u2013664","journal-title":"Am J Respir Crit Care Med"},{"key":"9217_CR2","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1513\/pats.200602-016TK","volume":"3","author":"N Walter","year":"2006","unstructured":"Walter N, Collard HR, King TE Jr (2006) Current perspectives on the treatment of idiopathic pulmonary fibrosis. Proc Am Thorac Soc 3:330\u2013338","journal-title":"Proc Am Thorac Soc"},{"key":"9217_CR3","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1183\/09031936.05.00145004","volume":"26","author":"D Bouros","year":"2005","unstructured":"Bouros D, Antoniou KM (2005) Current and future therapeutic approaches in idiopathic pulmonary fibrosis. Eur Respir J 26:693\u2013702","journal-title":"Eur Respir J"},{"key":"9217_CR4","doi-asserted-by":"crossref","unstructured":"American Thoracic Society\/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias (2002) Am J Respir Crit Care Med 165:277\u2013304","DOI":"10.1164\/ajrccm.165.2.ats01"},{"key":"9217_CR5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa030511","volume":"350","author":"G Raghu","year":"2004","unstructured":"Raghu G, Brown KK, Bradford WZ et al (2004) A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med 350:125\u2013133","journal-title":"N Engl J Med"},{"key":"9217_CR6","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1056\/NEJMoa042976","volume":"353","author":"M Demedts","year":"2005","unstructured":"Demedts M, Behr J, Buhl R et al (2005) High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 353:2229\u20132242","journal-title":"N Engl J Med"},{"key":"9217_CR7","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1164\/ajrccm.162.6.2003049","volume":"162","author":"AG Nicholson","year":"2000","unstructured":"Nicholson AG, Colby TV, Dubois RM et al (2000) The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 162:2213\u20132217","journal-title":"Am J Respir Crit Care Med"},{"key":"9217_CR8","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1164\/ajrccm\/144.2.291","volume":"144","author":"G Raghu","year":"1991","unstructured":"Raghu G, Depaso WJ, Cain K et al (1991) Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective, double-blind randomized, placebo-controlled clinical trial. Am Rev Respir Dis 144:291\u2013296","journal-title":"Am Rev Respir Dis"},{"key":"9217_CR9","first-page":"1789","volume":"33","author":"D Launay","year":"2006","unstructured":"Launay D, Remy-Jardin M, Michon-Pasturel U et al (2006) High resolution computed tomography in fibrosing alveolitis associated with systemic sclerosis. J Rheumatol 33:1789\u20131801","journal-title":"J Rheumatol"},{"key":"9217_CR10","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/clpt.2008.127","volume":"84","author":"A Wu","year":"2008","unstructured":"Wu A, Fuhlbrigge A (2008) Economic evaluation of pharmacogenetic tests. Clin Pharmacol Ther 84:272\u2013274","journal-title":"Clin Pharmacol Ther"},{"key":"9217_CR11","first-page":"820","volume":"36","author":"A Singh","year":"2007","unstructured":"Singh A (2007) Pharmacogenomics\u2014the potential of genetically guided prescribing. Aust Fam Physician 36:820\u2013824","journal-title":"Aust Fam Physician"},{"key":"9217_CR12","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1056\/NEJMoa0706135","volume":"358","author":"S Mallal","year":"2008","unstructured":"Mallal S, Phillips E, Carosi G et al (2008) HLA-B*5701 screening for hypersensitivity to abacavir. N Engl J Med 358:568\u2013579","journal-title":"N Engl J Med"},{"key":"9217_CR13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/01.GIM.0000153664.65759.CF","volume":"7","author":"S Sanderson","year":"2005","unstructured":"Sanderson S, Emery J, Higgins J (2005) CYP2C9 gene variants, drug dose, and bleeding risk in warfarin-treated patients: a HuGEnet systematic review and meta-analysis. Genet Med 7:97\u2013104","journal-title":"Genet Med"},{"key":"9217_CR14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.clpt.2006.04.006","volume":"80","author":"T Schalekamp","year":"2006","unstructured":"Schalekamp T, Brasse BP, Roijers JF et al (2006) VKORC1 and CYP2C9 genotypes and acenocoumarol anticoagulation status: interaction between both genotypes affects over-anticoagulation. Clin Pharmacol Ther 80:13\u201322","journal-title":"Clin Pharmacol Ther"},{"key":"9217_CR15","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/00007691-200404000-00017","volume":"26","author":"M Eichelbaum","year":"2004","unstructured":"Eichelbaum M, Fromm MF, Schwab M (2004) Clinical aspects of the MDR1 (ABCB1) gene polymorphism. Ther Drug Monit 26:180\u2013185","journal-title":"Ther Drug Monit"},{"key":"9217_CR16","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1056\/NEJMe0708842","volume":"358","author":"M Ingelman-Sundberg","year":"2008","unstructured":"Ingelman-Sundberg M (2008) Pharmacogenomic biomarkers for prediction of severe adverse drug reactions. N Engl J Med 358:637\u2013639","journal-title":"N Engl J Med"},{"key":"9217_CR17","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1183\/09031936.00026107","volume":"30","author":"D Perri","year":"2007","unstructured":"Perri D, Cole DE, Friedman O et al (2007) Azathioprine and diffuse alveolar haemorrhage: the pharmacogenetics of thiopurine methyltransferase. Eur Respir J 30:1014\u20131017","journal-title":"Eur Respir J"},{"key":"9217_CR18","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0009-9260(05)80993-6","volume":"45","author":"JR Flowers","year":"1992","unstructured":"Flowers JR, Clunie G, Burke M et al (1992) Bronchiolitis obliterans organizing pneumonia: the clinical and radiological features of seven cases and a review of the literature. Clin Radiol 45:371\u2013377","journal-title":"Clin Radiol"},{"key":"9217_CR19","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1046\/j.1365-2036.2002.01353.x","volume":"16","author":"A Ansari","year":"2002","unstructured":"Ansari A, Hassan C, Duley J et al (2002) Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease. Aliment Pharmacol Ther 16:1743\u20131750","journal-title":"Aliment Pharmacol Ther"},{"key":"9217_CR20","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00008571-200208000-00003","volume":"12","author":"M Schwab","year":"2002","unstructured":"Schwab M, Schaffeler E, Marx C et al (2002) Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: impact of thiopurine S-methyltransferase polymorphism. Pharmacogenetics 12:429\u2013436","journal-title":"Pharmacogenetics"},{"key":"9217_CR21","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1007\/s10620-006-9119-z","volume":"52","author":"JP Gisbert","year":"2007","unstructured":"Gisbert JP, Gomollon F, Cara C et al (2007) Thiopurine methyltransferase activity in Spain: a study of 14,545 patients. Dig Dis Sci 52:1262\u20131269","journal-title":"Dig Dis Sci"},{"key":"9217_CR22","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s002280050457","volume":"54","author":"T Kroplin","year":"1998","unstructured":"Kroplin T, Weyer N, Gutsche S et al (1998) Thiopurine S-methyltransferase activity in human erythrocytes: a new HPLC method using 6-thioguanine as substrate. Eur J Clin Pharmacol 54:265\u2013271","journal-title":"Eur J Clin Pharmacol"},{"key":"9217_CR23","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/978-1-4615-5381-6_142","volume":"431","author":"T Kroplin","year":"1998","unstructured":"Kroplin T, Weyer N, Iven H (1998) Determination of thiopurine methyltransferase activity in erythrocytes using 6-thioguanine as the substrate. Adv Exp Med Biol 431:741\u2013745","journal-title":"Adv Exp Med Biol"},{"key":"9217_CR24","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1046\/j.1365-2230.2001.00837.x","volume":"26","author":"SJ Meggitt","year":"2001","unstructured":"Meggitt SJ, Reynolds NJ (2001) Azathioprine for atopic dermatitis. Clin Exp Dermatol 26:369\u2013375","journal-title":"Clin Exp Dermatol"},{"key":"9217_CR25","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2036.2004.02124.x","volume":"20","author":"J Winter","year":"2004","unstructured":"Winter J, Walker A, Shapiro D et al (2004) Cost-effectiveness of thiopurine methyltransferase genotype screening in patients about to commence azathioprine therapy for treatment of inflammatory bowel disease. Aliment Pharmacol Ther 20:593\u2013599","journal-title":"Aliment Pharmacol Ther"},{"key":"9217_CR26","first-page":"156","volume":"43","author":"KT Oh","year":"2004","unstructured":"Oh KT, Anis AH, Bae SC (2004) Pharmacoeconomic analysis of thiopurine methyltransferase polymorphism screening by polymerase chain reaction for treatment with azathioprine in Korea. Rheumatology (Oxford) 43:156\u2013163","journal-title":"Rheumatology (Oxford)"},{"key":"9217_CR27","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.2217\/14622416.8.11.1511","volume":"8","author":"EA Fargher","year":"2007","unstructured":"Fargher EA, Eddy C, Newman W et al (2007) Patients\u2019 and healthcare professionals\u2019 views on pharmacogenetic testing and its future delivery in the NHS. Pharmacogenomics 8:1511\u20131519","journal-title":"Pharmacogenomics"},{"key":"9217_CR28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1517\/14622416.3.1.89","volume":"3","author":"HL McLeod","year":"2002","unstructured":"McLeod HL, Siva C (2002) The thiopurine S-methyltransferase gene locus\u2014implications for clinical pharmacogenomics. Pharmacogenomics 3:89\u201398","journal-title":"Pharmacogenomics"},{"key":"9217_CR29","doi-asserted-by":"crossref","first-page":"608","DOI":"10.7326\/0003-4819-126-8-199704150-00003","volume":"126","author":"CR Yates","year":"1997","unstructured":"Yates CR, Krynetski EY, Loennechen T et al (1997) Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance. Ann Intern Med 126:608\u2013614","journal-title":"Ann Intern Med"},{"key":"9217_CR30","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1365-2036.2003.01690.x","volume":"18","author":"RB Gearry","year":"2003","unstructured":"Gearry RB, Barclay ML, Burt MJ et al (2003) Thiopurine S-methyltransferase (TPMT) genotype does not predict adverse drug reactions to thiopurine drugs in patients with inflammatory bowel disease. Aliment Pharmacol Ther 18:395\u2013400","journal-title":"Aliment Pharmacol Ther"},{"key":"9217_CR31","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/hmg\/8.2.367","volume":"8","author":"MM Ameyaw","year":"1999","unstructured":"Ameyaw MM, Collie-Duguid ES, Powrie RH et al (1999) Thiopurine methyltransferase alleles in British and Ghanaian populations. Hum Mol Genet 8:367\u2013370","journal-title":"Hum Mol Genet"},{"key":"9217_CR32","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1365-2125.1996.tb00061.x","volume":"42","author":"IJ Jang","year":"1996","unstructured":"Jang IJ, Shin SG, Lee KH et al (1996) Erythrocyte thiopurine methyltransferase activity in a Korean population. Br J Clin Pharmacol 42:638\u2013641","journal-title":"Br J Clin Pharmacol"},{"key":"9217_CR33","first-page":"651","volume":"32","author":"RM Weinshilboum","year":"1980","unstructured":"Weinshilboum RM, Sladek SL (1980) Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet 32:651\u2013662","journal-title":"Am J Hum Genet"},{"key":"9217_CR34","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00008571-199902000-00006","volume":"9","author":"ES Collie-Duguid","year":"1999","unstructured":"Collie-Duguid ES, Pritchard SC, Powrie RH et al (1999) The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations. Pharmacogenetics 9:37\u201342","journal-title":"Pharmacogenetics"},{"key":"9217_CR35","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1080\/00365520410007980","volume":"39","author":"U Hindorf","year":"2004","unstructured":"Hindorf U, Lyrenas E, Nilsson A et al (2004) Monitoring of long-term thiopurine therapy among adults with inflammatory bowel disease. Scand J Gastroenterol 39:1105\u20131112","journal-title":"Scand J Gastroenterol"},{"key":"9217_CR36","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/01.fpc.0000114745.08559.db","volume":"14","author":"E Schaeffeler","year":"2004","unstructured":"Schaeffeler E, Fischer C, Brockmeier D et al (2004) Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants. Pharmacogenetics 14:407\u2013417","journal-title":"Pharmacogenetics"},{"key":"9217_CR37","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1067\/mcp.2000.108674","volume":"68","author":"L Yan","year":"2000","unstructured":"Yan L, Zhang S, Eiff B et al (2000) Thiopurine methyltransferase polymorphic tandem repeat: genotype-phenotype correlation analysis. Clin Pharmacol Ther 68:210\u2013219","journal-title":"Clin Pharmacol Ther"},{"key":"9217_CR38","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1378\/chest.127.1.171","volume":"127","author":"TE King Jr","year":"2005","unstructured":"King TE Jr, Safrin S, Starko KM et al (2005) Analyses of efficacy end points in a controlled trial of interferon-{gamma}1b for idiopathic pulmonary fibrosis. Chest 127:171\u2013177","journal-title":"Chest"},{"key":"9217_CR39","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/0002-9343(78)90855-0","volume":"65","author":"RH Winterbauer","year":"1978","unstructured":"Winterbauer RH, Hammar SP, Hallman KO et al (1978) Diffuse interstitial pneumonitis clinicopathologic correlations in 20 patients treated with prednisone\/azathioprine. Am J Med 65:661\u2013672","journal-title":"Am J Med"},{"key":"9217_CR40","doi-asserted-by":"crossref","first-page":"641","DOI":"10.7326\/0003-4819-111-8-641","volume":"111","author":"DH Present","year":"1989","unstructured":"Present DH, Meltzer SJ, Krumholz MP et al (1989) 6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity. Ann Intern Med 111:641\u2013649","journal-title":"Ann Intern Med"},{"key":"9217_CR41","unstructured":"www.drugstore.com . Accessed 10 Sept 2008"},{"key":"9217_CR42","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/j.rmed.2007.03.012","volume":"101","author":"HR Collard","year":"2007","unstructured":"Collard HR, Loyd JE, King TE Jr et al (2007) Current diagnosis and management of idiopathic pulmonary fibrosis: a survey of academic physicians. Respir Med 101:2011\u20132016","journal-title":"Respir Med"},{"key":"9217_CR43","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1524-4733.2007.00242.x","volume":"11","author":"A Eldar-Lissai","year":"2008","unstructured":"Eldar-Lissai A, Cosler LE, Culakova E et al (2008) Economic analysis of prophylactic pegfilgrastim in adult cancer patients receiving chemotherapy. Value Health 11:172\u2013179","journal-title":"Value Health"},{"key":"9217_CR44","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1200\/JCO.2005.09.102","volume":"23","author":"CL Vogel","year":"2005","unstructured":"Vogel CL, Wojtukiewicz MZ, Carroll RR et al (2005) First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: a multicenter, double-blind, placebo-controlled phase III study. J Clin Oncol 23:1178\u20131184","journal-title":"J Clin Oncol"},{"key":"9217_CR45","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0924-8579(00)00235-1","volume":"16","author":"JA Talcott","year":"2000","unstructured":"Talcott JA (2000) Outpatient management of febrile neutropenia. Int J Antimicrob Agents 16:169\u2013171","journal-title":"Int J Antimicrob Agents"},{"key":"9217_CR46","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.2169\/internalmedicine.46.6218","volume":"46","author":"H Tomioka","year":"2007","unstructured":"Tomioka H, Imanaka K, Hashimoto K et al (2007) Health-related quality of life in patients with idiopathic pulmonary fibrosis\u2014cross-sectional and longitudinal study. Intern Med 46:1533\u20131542","journal-title":"Intern Med"},{"key":"9217_CR47","doi-asserted-by":"crossref","first-page":"117S","DOI":"10.1378\/chest.124.4_MeetingAbstracts.150S-c","volume":"124","author":"F Martinez","year":"2003","unstructured":"Martinez F, Bradford W, Safrin S et al (2003) Rates and characteristics of death in patients with idiopathic pulmonary fibrosis (IPF). Chest 124:117S","journal-title":"Chest"},{"key":"9217_CR48","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1164\/rccm.200209-1112OC","volume":"168","author":"KR Flaherty","year":"2003","unstructured":"Flaherty KR, Mumford JA, Murray S et al (2003) Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 168:543\u2013548","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-009-9217-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00408-009-9217-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-009-9217-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T18:37:49Z","timestamp":1559068669000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00408-009-9217-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,12]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["9217"],"URL":"https:\/\/doi.org\/10.1007\/s00408-009-9217-8","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"value":"0341-2040","type":"print"},{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,12]]}}}